Brokerages Set Palvella Therapeutics (NASDAQ:PVLA) Price Target at $44.43
Palvella Therapeutics (NASDAQ:PVLA – Get Free Report) has earned a consensus recommendation of “Buy” from the eight analysts that are currently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among […]
Palvella Therapeutics (NASDAQ:PVLA – Get Free Report) has earned a consensus recommendation of “Buy” from the eight analysts that are currently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among […]
